I-peptide ehamba phambili ye-CRDMO KWI-PHARMACRUTICAL & COSMETIC

[Umgca wePeptides]
 
Iindlela zokuSebenza: i-SPPS, i-LPPS, i-L / SPPS, i-MPSPPS, i-HPPS
Amava: Ulandelelwano lwePeptide ukusuka kwi-2 ukuya kwi-80 amino acids; ngaphezulu kwama-20,000 emigca yeepeptide eziswa kubathengi
Isikali seMveliso: Ukusuka kwi-milligram ukuya kwi-multi-hund-kilogram scale
Iinketho zoMgangatho: Ikrwada, ≥90%, ≥95%, ≥98%, ≥99% ubunyulu, ilungiselelwe ukuhlangabezana neemfuno ezahlukeneyo zomgangatho
Ixesha lokukhokela: Kwiipeptides phantsi kwe-30 amino acids (mg isikali), ukuhanjiswa ngokukhawuleza kwiiveki ze-2-3

 
[Cyclic Peptides]
 
Ubuchule bokuhamba ngebhayisikile: Iibhondi zeDisulfide (1–3 ngababini), iibhondi ze-thioether, iibhondi ze-amide, iibhondi ze-ester, iikhemikhali zokucofa, iibhondi ze-olefin
IiNdawo zokuhamba ngebhayisikile: Intloko ukuya emsileni, ikhonkco ukuya kwelinye icala, iC-terminal-to-side-chain, N-terminal-to-side-chain
Amava: Ulandelelwano ukusuka kwi-4 ukuya kwi-80 i-amino acids; ngaphezulu kwe-5,000 yeepeptides zebhayisikile zinikezelwe ngempumelelo
Isikali seMveliso: Ukusuka kwi-milligram ukuya kwi-multi-hund-kilogram scale
Iinketho zoMgangatho: Ukrwada, ≥90%, ≥95%, ≥98%, ≥99% ubunyulu
Ixesha lokukhokela: Kwi-peptides ye-monocyclic phantsi kwe-30 amino acids (i-mg scale), ukuhanjiswa ngokukhawuleza kwiiveki ze-2-3

[IiPeptides eModified]
 
Iindidi zoLungiso: I-acetylation, i-alkylation, ukuguqulwa kwe-long-chain, isotope labeling, i-fluorescent kunye nedayi yokubhala, i-glycosylation, i-phosphorylation, i-esterification, ukuguqulwa kwesakhiwo esithile, i-PEGylation, kunye nokunye.
IiNdawo zoLungiso: I-N-terminal, i-C-terminal, amatyathanga asecaleni
Amava: Ulandelelwano ukusuka kwi-2 ukuya kwi-80 amino acids; ngaphezu kwama-5,000 eepeptides ezilungisiweyo zihanjiswe ngempumelelo
Isikali seMveliso: Ukusuka kwi-milligram ukuya kwi-multi-hund-kilogram scale
Iinketho zoMgangatho: Ukrwada, ≥90%, ≥95%, ≥98%, ≥99% ubunyulu
Ixesha lokukhokela: Kwi-peptides elungisiweyo phantsi kwe-30 amino acids (mg scale), ukuhanjiswa ngokukhawuleza kwiiveki ze-2-3

[Neoantigen Peptides]
 
Umda weNkonzo: Ukuhlolwa kokulandelelana, uphuhliso lwenkqubo, uphando olusemgangathweni, inkxaso yokufaka i-IND, ukuveliswa kwe-GMP
Amava: Ulandelelwano ukusuka kwi-5 ukuya kwi-30 ye-amino acids; ngaphezulu kwe-100 ye-neoantigen peptides ihanjiswe ngempumelelo
Isikali seMveliso: Ukusuka kwi-milligram ukuya kwisikali segram
Iinketho zoMgangatho: ≥95%, ≥98%, ≥99% ubunyulu
Ixesha lokukhokela: Kwi-peptides ye-neoantigen phantsi kwe-30 amino acids (isikali se-mg), ukuhanjiswa ngokukhawuleza kwiiveki ze-2-3
 
[Peptide Conjugates]
Iindidi zokudibanisa: ii-PDC, ii-RDCs, i-peptide-drug conjugates, i-peptide-natural compound conjugates, kunye nokunye.
Amava: Ngaphezu kwe-100 ye-peptide conjugates ethunyelwe ngempumelelo
Isikali seMveliso: Ukusuka kwimilligram ukuya kwisikali sekhilogram
Iinketho zoMgangatho: ≥95%, ≥98%, ≥99% ubunyulu
Ixesha lokukhokela: Kwi-peptide conjugates phantsi kwe-30 amino acids (mg scale), ukuhanjiswa ngokukhawuleza kwiiveki ze-2-3

[Ezinye iiPeptides]
 
Umda weNkonzo: Iipeptide ezinamasebe, iipeptide ezizihlanganisayo, iipeptide ezingena kwiseli, iipeptides ezizii-semi-synthetic, njl.
Amava: Ulandelelwano ukusuka kwi-5 ukuya kwi-88 amino acids; ngaphezulu kwe-1,000 yeepeptides ezikhethekileyo zihanjiswe ngempumelelo
Isikali seMveliso: Ukusuka kwimilligram ukuya kwisikali sekhilogram
Iinketho zoMgangatho: Ukrwada, ≥90%, ≥95%, ≥98%, ≥99% ubunyulu
Ixesha lokukhokela: Kwiipeptides ezikhethekileyo phantsi kwe-30 amino acids (mg isikali), ukuhanjiswa ngokukhawuleza kwiiveki ze-2-3